PENTAM Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Pentam, and what generic alternatives are available?
Pentam is a drug marketed by Fresenius Kabi Usa, Seton Pharms, X-gen Pharms Inc, Avet Lifesciences, Baxter Hlthcare, Hospira, Watson Labs, and Xgen Pharms. and is included in nine NDAs.
The generic ingredient in PENTAM is pentamidine isethionate. There are fourteen drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the pentamidine isethionate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Pentam
A generic version of PENTAM was approved as pentamidine isethionate by SETON PHARMS on September 28th, 2017.
Summary for PENTAM
| US Patents: | 0 |
| Applicants: | 8 |
| NDAs: | 9 |
| Finished Product Suppliers / Packagers: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 104 |
| Clinical Trials: | 1 |
| Patent Applications: | 1,629 |
| Formulation / Manufacturing: | see details |
| Drug Prices: | Drug price information for PENTAM |
| DailyMed Link: | PENTAM at DailyMed |
Recent Clinical Trials for PENTAM
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| University of Illinois at Chicago |
Pharmacology for PENTAM
| Drug Class | Antiprotozoal |
Anatomical Therapeutic Chemical (ATC) Classes for PENTAM
US Patents and Regulatory Information for PENTAM
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Fresenius Kabi Usa | PENTAM | pentamidine isethionate | INJECTABLE;INJECTION | 019264-001 | Oct 16, 1984 | AP | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
| Seton Pharms | PENTAMIDINE ISETHIONATE | pentamidine isethionate | INJECTABLE;INJECTION | 206666-001 | Sep 28, 2017 | AP | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
| Avet Lifesciences | PENTAMIDINE ISETHIONATE | pentamidine isethionate | INJECTABLE;INJECTION | 213806-001 | Jan 7, 2021 | AP | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
| Watson Labs | PENTAMIDINE ISETHIONATE | pentamidine isethionate | INJECTABLE;INJECTION | 074303-001 | Aug 17, 1995 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Seton Pharms | PENTAMIDINE ISETHIONATE | pentamidine isethionate | FOR SOLUTION;INHALATION | 206667-001 | Apr 24, 2019 | AN | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
